Texas 2019 86th Regular

Texas House Bill HR479 Enrolled / Bill

Filed 03/14/2019

                    H.R. No. 479


 R E S O L U T I O N
 WHEREAS, Prostate cancer is the second most common type of
 cancer and the second leading cause of cancer death among American
 men; and
 WHEREAS, One in every nine men is diagnosed with prostate
 cancer over the course of his lifetime, and in 2019, experts
 estimate that there will be nearly 175,000 new cases and more than
 31,500 deaths from prostate cancer; this year, approximately 10,660
 Texas men are expected to be diagnosed and another 1,900 Texans will
 die from the disease; and
 WHEREAS, Although prostate cancer affects men of all races
 and socioeconomic levels, African Americans are at an increased
 risk; overall, African American men are 1.7 times more likely to be
 diagnosed with and 2.3 times more likely to die from prostate cancer
 than white men; African American men are also slightly more likely
 than white men to be diagnosed with advanced stages of the disease,
 which coincide with a far less optimistic prognosis; and
 WHEREAS, Early detection and treatment offer prostate cancer
 patients the best hope for a full recovery, and improving patient
 outcomes depends a great deal on increasing public awareness of
 prostate cancer and its risk factors; men are advised to consult
 with their physicians to assess their individual risk of developing
 prostate cancer and to determine whether screenings and other tests
 are appropriate; and
 WHEREAS, Additional focus is needed on the personal and
 social burdens of prostate cancer in order to provide patients,
 their families, and their caregivers the support they require;
 individuals diagnosed with prostate cancer can benefit from
 learning about the disease from health care providers, as well as
 from taking advantage of support groups and other resources to help
 them better cope with their illness and treatment process; and
 WHEREAS, There are more scientific studies to be done to keep
 the medical community on the leading edge of prostate cancer
 treatments, and the observance of Prostate Cancer Awareness Month
 in September is an opportunity for the State of Texas to affirm its
 commitment to prostate cancer research as a priority of great
 importance; now, therefore, be it
 RESOLVED, That the House of Representatives of the 86th Texas
 Legislature hereby recognize September 2019 as Prostate Cancer
 Awareness Month and encourage Texans to seek out more information
 about prostate cancer.
 Dutton
 ______________________________
 Speaker of the House
 I certify that H.R. No. 479 was adopted by the House on March
 13, 2019, by a non-record vote.
 ______________________________
 Chief Clerk of the House